Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who undergo surgery or procedures with general anaesthesia or deep sedation.
UK Drug Safety Update · January 28, 2025
GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
Original title: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
Healthcare professionals warned of pulmonary aspiration risk in patients on GLP-1 or GIP/GLP-1 agonists undergoing general anaesthesia or deep sedation.
Published by UK Drug Safety Update. HealthSignal links to the original document; the summary above is extracted from the source text.